Literature DB >> 7436483

Treatment of mesangiocapillary glomerulonephritis in children with combined immunosuppression and anticoagulation.

S J Chapman, J S Cameron, C Chantler, D Turner.   

Abstract

10 children with mesangiocapillary (membranoproliferative) glomerulonephritis with features associated with a poor prognosis (either crescentic nephritis or a decline in renal function occurring after the initial presentation) were treated with a combination of immunosuppression and anticoagulation using corticosteroids, azathioprine, and heparin followed by warfarin and dipyridamole. Children were followed up for between 2 and 5 years, and at the end of this period 2 had died and 2 had entered the dialysis/transplant programme, but 6 were well (5 with glomerular filtration rates greater than 65 ml/min per 1 x 73 m2). We suggest that these results are sufficiently promising to encourage further trials of this form of treatment.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7436483      PMCID: PMC1626945          DOI: 10.1136/adc.55.6.446

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  "Pulse" methylprednisolone therapy in the treatment of severe glomerulonephritis.

Authors:  B R Cole; J T Brocklebank; R A Kienstra; J M Kissane; A M Robson
Journal:  J Pediatr       Date:  1976-02       Impact factor: 4.406

2.  A kinetic evaluation of hemostasis in renal disease.

Authors:  C R George; S J Slichter; L J Quadracci; G E Striker; L A Harker
Journal:  N Engl J Med       Date:  1974-11-21       Impact factor: 91.245

3.  The effect of defibrination on nephrotoxic serum nephritis in rabbits.

Authors:  P Naish; G B Penn; D J Evans; D K Peters
Journal:  Clin Sci       Date:  1972-05       Impact factor: 6.124

4.  Idiopathic membranoproliferative glomerulonephritis in children. Report of 105 cases.

Authors:  R Habib; C Kleinknecht; M C Gubler; M Levy
Journal:  Clin Nephrol       Date:  1973 Jul-Aug       Impact factor: 0.975

5.  Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis.

Authors:  C B Brown; D Wilson; D Turner; J S Cameron; C S Ogg; C Chantler; D Gill
Journal:  Lancet       Date:  1974-11-16       Impact factor: 79.321

6.  Anticoagulants in "irreversible" acute renal failure.

Authors:  P Kincaid-Smith; B M Saker; K F Fairley
Journal:  Lancet       Date:  1968-12-28       Impact factor: 79.321

7.  The treatment of chronic mesangiocapillary (membranoproliferative) glomerulonephritis with impaired renal function.

Authors:  P Kincaid-Smith
Journal:  Med J Aust       Date:  1972-09-09       Impact factor: 7.738

8.  Anticoagulants in renal disease in children.

Authors:  R C Herdman; R Edson; R J Pickering; A J Fish; S Marker; R A Good
Journal:  Am J Dis Child       Date:  1970-01

9.  Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA.

Authors:  C Chantler; E S Garnett; V Parsons; N Veall
Journal:  Clin Sci       Date:  1969-08       Impact factor: 6.124

10.  Mesangiocapillary glomerulonephritis: changes in glomerular morphology with long-term alternate-day prednisone therapy.

Authors:  A J McAdams; P T McEnery; C D West
Journal:  J Pediatr       Date:  1975-01       Impact factor: 4.406

View more
  10 in total

1.  Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone--a report of the International Study of Kidney Disease in Children.

Authors:  P Tarshish; J Bernstein; J N Tobin; C M Edelmann
Journal:  Pediatr Nephrol       Date:  1992-03       Impact factor: 3.714

Review 2.  The treatment of immune glomerular disease.

Authors:  D G Williams
Journal:  Springer Semin Immunopathol       Date:  1987

3.  Long-term follow-up of diffuse membranoproliferative glomerulonephritis type I.

Authors:  Takeshi Yanagihara; Mari Hayakawa; Junko Yoshida; Masami Tsuchiya; Toshisada Morita; Mutsumi Murakami; Yoshitaka Fukunaga
Journal:  Pediatr Nephrol       Date:  2005-03-22       Impact factor: 3.714

4.  Gaucher's disease and mesangiocapillary glomerulonephritis in childhood--a coincidence?

Authors:  R Halevi; M Davidovitz; S Mann; M Ben-Bassat; H Stark; B Eisenstein
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

5.  Transition of children with membranoproliferative glomerulonephritis to adolescence and adulthood.

Authors:  Kikuo Iitaka; Osamu Motoyama; Shinya Nakamura; Hiroe Koshino; Tadasu Sakai
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

Review 6.  The treatment of glomerulonephritis in children.

Authors:  G B Haycock
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

7.  C3 nephritic factor associated with C3 glomerulopathy in children.

Authors:  Camille Nicolas; Vincent Vuiblet; Veronique Baudouin; Marie-Alice Macher; Isabele Vrillon; Nathalie Biebuyck-Gouge; Maud Dehennault; Sophie Gié; Denis Morin; Hubert Nivet; François Nobili; Tim Ulinski; Bruno Ranchin; Maria Chiarra Marinozzi; Stéphanie Ngo; Véronique Frémeaux-Bacchi; Christine Pietrement
Journal:  Pediatr Nephrol       Date:  2013-09-26       Impact factor: 3.714

8.  Non-nephrotic children with membranoproliferative glomerulonephritis: are steroids indicated?

Authors:  M Somers; S Kertesz; S Rosen; J Herrin; R Colvin; N Palacios de Carreta; M Kim
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

9.  Idiopathic membranoproliferative glomerulonephritis in Japanese children.

Authors:  K Iitaka; T Ishidate; M Hojo; S Kuwao; N Kasai; T Sakai
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

10.  Chapter 8: Idiopathic membranoproliferative glomerulonephritis.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.